UNCY – unicycive therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Form 8-K Unicycive Therapeutics, For: Nov 14
Form 424B5 Unicycive Therapeutics,
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.